loading

Cognition Therapeutics Inc Azioni (CGTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
54.39%
6.375
13.98 13.78 10.72 14.46
Operating Income/Loss
54.39%
-6.375
-13.98 -13.78 -10.72 -14.46
Income/Loss From Continuing Operations Before Tax
26.79%
-4.93
-6.734 -8.48 -7.842 -9.937
Income/Loss From Continuing Operations After Tax
26.79%
-4.93
-6.734 -8.48 -7.842 -9.937
Net Income/Loss
26.79%
-4.93
-6.734 -8.48 -7.842 -9.937
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
22.39%
77.95
63.69 61.83 1.6495 40.42
Diluted Average Shares
22.39%
77.95
63.69 61.83 1.6495 40.42
Basic Earnings Per Share
45.45%
-0.06
-0.11 -0.14 -0.17 -0.25
Diluted Earnings Per Share
45.45%
-0.06
-0.11 -0.14 -0.17 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):